van Haastert; Rick Jan

Patent Applications and Registrations

Patent applications and USPTO patent grants for van Haastert; Rick Jan.The latest application filed is for "mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway".

Company Profile

2.4.5

van Haastert; Rick Jan - Amersfoort NL
Van Haastert; Rick Jan - Amersfoot NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway Grant 10,583,149 - Berezikov , et al.	2020-03-10
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway Grant 10,201,556 - van Haastert , et al. Feb	2019-02-12
MiRNA for treating diseases and conditions associated with neo-angiogenesis Grant 10,023,868 - Weijzen , et al. July 17, 2	2018-07-17
MiRNA and its Diagnostic and Therapeutic Uses in Diseases or Conditions Associated with Melanoma, or in Diseases or Conditions Associated with Activated BRAF Pathway App 20170304348 - Berezikov; Eugene ; et al.	2017-10-26
Mirna For Treating Diseases And Conditions Associated With Neo-angiogenesis App 20160333353 - WEIJZEN; Sanne ; et al.	2016-11-17
MiRNA for treating diseases and conditions associated with neo-angiogenesis Grant 9,441,222 - Weijzen , et al. September 13, 2	2016-09-13
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway App 20150297626 - van Haastert; Rick Jan ; et al.	2015-10-22
MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis App 20140005251 - WEIJZEN; Sanne ; et al.	2014-01-02
MiRNA AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH MELANOMA, OR IN DISEASES OR CONDITIONS ASSOCIATED WITH ACTIVATED BRAF PATHWAY App 20130109741 - Berezikov; Eugene ; et al.	2013-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.